Clinical Trials Browser

Phase 2 × Interventional × carotuximab × Clear all

NCT05534646 2026-02-02

Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer

Phase 2 Recruiting

Prostatic Neoplasms

NCT03418324 2020-12-30

Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy

Phase 2 Completed

11 enrolled 17 charts

Prostatic Neoplasms

NCT02664961 2019-07-23

Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)

Phase 2 Terminated

3 enrolled 11 charts

Choriocarcinoma, Trophoblastic Tumor, Placental Site, Gestational Trophoblastic Disease

NCT01564914 2019-06-12

105GM201

Phase 2 Completed

22 enrolled 11 charts

Glioblastoma

NCT02396511 2019-06-11

TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma

Phase 2 Completed

2 enrolled 10 charts

Choriocarcinoma

NCT01381861 2019-03-05

Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

Phase 2 Completed

23 enrolled 12 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01727089 2018-08-28

Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer

Phase 2 Completed

59 enrolled 12 charts

Carcinoma, Renal Cell

NCT01375569 2017-07-28

TRC105 for Liver Cancer That Has Not Responded to Sorafenib

Phase 2 Completed

11 enrolled 10 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01328574 2017-01-13

TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma

Phase 2 Completed

13 enrolled 15 charts

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms